Sight Sciences, Inc.
SGHT
$8.36
-$0.03-0.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 76.05M | 76.30M | 78.11M | 79.87M | 79.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 76.05M | 76.30M | 78.11M | 79.87M | 79.54M |
| Cost of Revenue | 10.61M | 11.15M | 11.20M | 11.58M | 11.84M |
| Gross Profit | 65.44M | 65.15M | 66.91M | 68.29M | 67.70M |
| SG&A Expenses | 94.34M | 95.98M | 98.79M | 100.83M | 100.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 121.41M | 124.99M | 127.78M | 130.40M | 129.26M |
| Operating Income | -45.36M | -48.68M | -49.67M | -50.53M | -49.71M |
| Income Before Tax | -46.07M | -48.72M | -49.14M | -51.27M | -50.14M |
| Income Tax Expenses | 40.00K | 285.00K | 260.00K | 236.00K | 208.00K |
| Earnings from Continuing Operations | -46.11 | -49.01 | -49.40 | -51.51 | -50.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.11M | -49.01M | -49.40M | -51.51M | -50.35M |
| EBIT | -45.36M | -48.68M | -49.67M | -50.53M | -49.71M |
| EBITDA | -44.81M | -48.08M | -49.00M | -49.82M | -49.02M |
| EPS Basic | -0.90 | -0.96 | -0.98 | -1.03 | -1.01 |
| Normalized Basic EPS | -0.56 | -0.60 | -0.61 | -0.62 | -0.61 |
| EPS Diluted | -0.90 | -0.96 | -0.98 | -1.03 | -1.01 |
| Normalized Diluted EPS | -0.56 | -0.60 | -0.61 | -0.62 | -0.61 |
| Average Basic Shares Outstanding | 206.29M | 204.25M | 202.33M | 200.53M | 198.63M |
| Average Diluted Shares Outstanding | 206.29M | 204.25M | 202.33M | 200.53M | 198.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |